Idexx Laboratories (IDXX)
Nasdaq Market Closed
IDEXX Laboratories, Inc. is a global animal health diagnostics company best known for serving veterinary practices, livestock producers, and animal health professionals. The company develops, manufactures, and sells diagnostic instruments, consumables, reference laboratory services, and software that help veterinarians detect disease, monitor treatment, and manage clinical workflows.
Its companion animal business is the core of the company. IDEXX supplies in-clinic analyzers for chemistry, hematology, urinalysis, and other testing, along with single-use diagnostic kits for common canine and feline conditions. These products allow veterinarians to produce results during a patient visit, improving the speed of diagnosis and treatment decisions. IDEXX also operates a network of reference laboratories that handle more complex or high-volume testing for veterinary clinics.
Beyond diagnostics, the company provides practice management software, client communication tools, and data services used by animal hospitals to run daily operations. These products connect clinical testing with appointment scheduling, medical records, billing, and customer engagement, making IDEXX an important technology supplier as well as a laboratory and medical device company.
IDEXX also serves livestock and poultry markets with tests used to detect, monitor, and manage infectious diseases in herd and flock health programs. In addition, the company has businesses related to water testing and other diagnostic applications.
Listed under the IDXX symbol, IDEXX benefits from long-term trends such as rising pet ownership, greater spending on companion animal care, and increased use of diagnostics in veterinary medicine. A meaningful portion of its revenue comes from outside the United States, giving the company exposure to international growth in pet healthcare and food animal disease monitoring.
Last updated
- Market Cap
- 44.23B
- P/E
- 40.39
- P/FCF
- 40.82
- P/S
- 9.95
- Enterprise Value
- 45.01B
- Sector
- Health Care
- Industry
- In Vitro and In Vivo Diagnostic Substances
- Address
- ONE IDEXX DRIVE, WESTBROOK, ME, 04092-2041
Veterinary Reference Laboratory Market Size to Reach USD 13.93 Billion by 2035 with 8.58% CAGR – SNS Insider
Veterinary Oncology Market Shares, Competition and Trends Analysis 2025-2030: Discover the Impact of Advanced Therapies and Digital Tools
Veterinary practice management software market to grow at a CAGR of 8% during the forecast period (2025 – 2030): Wissen Research
Global Swine Healthcare Market Size To Worth USD 5.96 Billion By 2033 | CAGR of 8.16% - GlobeNewswire
U.S. Companion Animal Diagnostics Market Insights, - GlobeNewswire
IDEXX (IDXX) Business Faces Macroeconomic Woes, FX Headwinds
Why Is Penumbra (PEN) Down 4.8% Since Last Earnings Report?
IDEXX (IDXX) Expands Test Menu for the Catalyst Platform
Why Is Idexx (IDXX) Up 5% Since Last Earnings Report?
IDEXX (IDXX) Witnesses Rising Expenses, Currency Issues
IDEXX (IDXX) Q1 Earnings Surpass Estimates, 2024 View Slashed
Compared to Estimates, Idexx (IDXX) Q1 Earnings: A Look at Key Metrics
Idexx Laboratories (IDXX) Tops Q1 Earnings Estimates
Bruker's (BRKR) Balanced Segmental Growth, Innovation Aid
Philips (PHG) Receives FDA Warning Letter Regarding CT Systems
DexCom (DXCM) Q1 Earnings Beat, Strong CGM Demand Continues
Revvity's (RVTY) New Launch to Boost Tuberculosis Testing
CONMED (CNMD) Q1 Earnings & Revenues Surpass Estimates
Veeva's (VEEV) AI Partner Program to Develop GenAI Solutions
West Pharmaceutical (WST) Q1 Earnings Beat, HVP Sales Weak
- Market Cap
Market cap is the total value of a company's shares, calculated by multiplying the stock price by the number of shares outstanding.
- 44.23B
- Enterprise Value
Enterprise value is the total value of a company, including its market cap, debt, and cash.
- 45.01B
- P/E
P/E ratio compares a company's share price to its earnings per share.
- 40.39
- P/B
P/B ratio compares a company's share price to its book value per share.
- 28.42
- P/S
P/S ratio compares a company's share price to its revenue per share.
- 9.95
- EV / EBITDA
EV/EBITDA measures a company's value compared to its earnings before interest, taxes, depreciation, and amortization.
- 28.95
- EV / Sales
EV/Sales measures a company's value compared to its total revenue.
- 10.12
- EPS
- 13.88
- Dividend Yield
Dividend yield shows how much a company pays in dividends each year compared to its share price.
- 0%
- P/FCF
Price-to-free-cash-flow ratio compares a company's share price to the cash it generates after expenses and investments.
- 40.82
- P/CF
P/CF ratio compares a company's share price to the cash flow it generates from its operations.
- 36.55
- Free Cash Flow
Free cash flow is the cash a company has left after covering operating costs and capital expenses.
- 1.08B
- ROE
ROE measures how effectively a company uses shareholders' equity to generate profit.
- 70.38%
- ROA
ROA measures how effectively a company uses its assets to generate profit.
- 32.35%
- Debt / Equity
Debt-to-equity ratio compares a company's total debt to its shareholders' equity.
- 0.63
- Current Ratio
Current ratio measures a company's ability to pay short-term debts using its short-term assets.
- 1.12
- Quick Ratio
Quick ratio measures a company's ability to pay short-term debts using cash and other easily available assets.
- 0.82
- Cash
Cash ratio measures a company's ability to cover short-term debts using only cash and cash equivalents.
- 0.15
- Avg Volume
Average volume shows the average number of shares traded over the last 30 trading days, helping indicate liquidity.
- 656.32K
- Fundamentals Snapshot Price
Fundamentals snapshot price is the stock price used when calculating the company's financial ratios and metrics.
- 560.73
Income Statement
| Line Item | 2026 Q1 | 2025 Q4 | 2025 Q3 | 2025 Q2 | 2025 Q1 |
|---|---|---|---|---|---|
| Revenue | 1.14B | 1.09B | 1.11B | 1.11B | 998.43M |
| Gross profit | 722.74M | 658.11M | 683.35M | 694.73M | 623.38M |
| Operating income | 362.59M | 315.61M | 354.85M | 373.05M | 316.53M |
| EBITDA | 400.27M | 354.33M | 391.47M | 408.82M | 350.6M |
| Net income | 278.45M | 248.19M | 274.61M | 293.99M | 242.68M |
| Basic EPS | 3.5 | 3.11 | 3.43 | 3.66 | 2.98 |
| Diluted EPS | 3.47 | 3.09 | 3.4 | 3.63 | 2.96 |
Balance Sheet
| Line Item | 2026 Q1 | 2025 Q4 | 2025 Q3 | 2025 Q2 | 2025 Q1 |
|---|---|---|---|---|---|
| Total assets | 3.39B | 3.35B | 3.39B | 3.33B | 3.21B |
| Total liabilities | 1.83B | 1.75B | 1.83B | 1.87B | 1.77B |
| Total equity | 1.56B | 1.61B | 1.56B | 1.46B | 1.45B |
| Cash & equivalents | 200.53M | 180.07M | 208.17M | 164.59M | 163.97M |
| Current assets | 1.45B | 1.41B | 1.48B | 1.36B | 1.32B |
| Current liabilities | 1.3B | 1.15B | 1.25B | 1.22B | 1.14B |
Cash Flow
| Line Item | 2026 Q1 | 2025 Q4 | 2025 Q3 | 2025 Q2 | 2025 Q1 |
|---|---|---|---|---|---|
| Operating cash flow | 266.25M | 355.76M | 402.34M | 185.74M | 237.96M |
| Investing cash flow | -33.54M | -28.13M | -44.87M | -33.63M | -29.61M |
| Financing cash flow | -211.43M | -355.7M | -313.31M | -165.63M | -330.32M |
| Change in cash | 20.46M | -28.1M | 43.57M | 624K | -124.3M |
| Kind | Filing | Date | Link |
|---|---|---|---|
| edgar index | 4 — IDEXX LABORATORIES INC /DE | View Filing | |
| edgar index | SD — IDEXX LABORATORIES INC /DE | View Filing | |
| form 4 | Form 4 — FENNELL GEORGE | View Filing | |
| form 4 | Form 4 — FENNELL GEORGE | View Filing | |
| form 4 | Form 4 — FENNELL GEORGE | View Filing | |
| edgar index | 144 — IDEXX LABORATORIES INC /DE | View Filing | |
| edgar index | 8-K — IDEXX LABORATORIES INC /DE | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| edgar index | 4 — IDEXX LABORATORIES INC /DE | View Filing | |
| edgar index | 4 — IDEXX LABORATORIES INC /DE | View Filing | |
| edgar index | 4 — IDEXX LABORATORIES INC /DE | View Filing | |
| edgar index | 4 — IDEXX LABORATORIES INC /DE | View Filing | |
| edgar index | 4 — IDEXX LABORATORIES INC /DE | View Filing | |
| edgar index | 4 — IDEXX LABORATORIES INC /DE | View Filing | |
| edgar index | 4 — IDEXX LABORATORIES INC /DE | View Filing | |
| edgar index | 4 — IDEXX LABORATORIES INC /DE | View Filing | |
| edgar index | 4 — IDEXX LABORATORIES INC /DE | View Filing | |
| form 4 | Form 4 — Britt Irene Chang | View Filing | |
| form 4 | Form 4 — Britt Irene Chang | View Filing | |
| form 4 | Form 4 — Claflin Bruce L. | View Filing | |
| form 4 | Form 4 — Claflin Bruce L. | View Filing | |
| form 4 | Form 4 — ESSIG STUART | View Filing | |
| form 4 | Form 4 — ESSIG STUART | View Filing | |
| form 4 | Form 4 — HOOLEY JOSEPH L | View Filing | |
| form 4 | Form 4 — HOOLEY JOSEPH L | View Filing | |
| form 4 | Form 4 — JUNIUS DANIEL M | View Filing | |
| form 4 | Form 4 — JUNIUS DANIEL M | View Filing | |
| form 4 | Form 4 — Kingsley Lawrence D | View Filing | |
| form 4 | Form 4 — Kingsley Lawrence D | View Filing | |
| form 4 | Form 4 — Kingsley Lawrence D | View Filing | |
| form 4 | Form 4 — Kingsley Lawrence D | View Filing | |
| form 4 | Form 4 — Peacock Karen | View Filing | |
| form 4 | Form 4 — Peacock Karen | View Filing | |
| form 4 | Form 4 — SAMAD SAM | View Filing | |
| form 4 | Form 4 — SAMAD SAM | View Filing | |
| form 4 | Form 4 — Vandebroek Sophie V. | View Filing | |
| form 4 | Form 4 — Vandebroek Sophie V. | View Filing | |
| edgar index | 4 — IDEXX LABORATORIES INC /DE | View Filing | |
| edgar index | 4 — IDEXX LABORATORIES INC /DE | View Filing | |
| edgar index | 4 — IDEXX LABORATORIES INC /DE | View Filing | |
| edgar index | 4 — IDEXX LABORATORIES INC /DE | View Filing | |
| edgar index | 4 — IDEXX LABORATORIES INC /DE | View Filing | |
| edgar index | 4 — IDEXX LABORATORIES INC /DE | View Filing | |
| form 4 | Form 4 — HOOLEY JOSEPH L | View Filing | |
| form 4 | Form 4 — HOOLEY JOSEPH L | View Filing | |
| form 4 | Form 4 — JUNIUS DANIEL M | View Filing | |
| form 4 | Form 4 — JUNIUS DANIEL M | View Filing | |
| form 4 | Form 4 — Kingsley Lawrence D | View Filing | |
| form 4 | Form 4 — Kingsley Lawrence D | View Filing | |
| form 4 | Form 4 — Kingsley Lawrence D | View Filing | |
| form 4 | Form 4 — Kingsley Lawrence D | View Filing | |
| form 4 | Form 4 — Peacock Karen | View Filing | |
| form 4 | Form 4 — Peacock Karen | View Filing | |
| form 4 | Form 4 — SZOSTAK M ANNE | View Filing | |
| form 4 | Form 4 — SZOSTAK M ANNE | View Filing | |
| form 4 | Form 4 — SZOSTAK M ANNE | View Filing | |
| form 4 | Form 4 — SZOSTAK M ANNE | View Filing | |
| form 4 | Form 4 — Vandebroek Sophie V. | View Filing | |
| form 4 | Form 4 — Vandebroek Sophie V. | View Filing | |
| form 4 | Form 4 — Vandebroek Sophie V. | View Filing | |
| edgar index | 10-Q — IDEXX LABORATORIES INC /DE | View Filing | |
| edgar index | 8-K — IDEXX LABORATORIES INC /DE | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| edgar index | 4 — IDEXX LABORATORIES INC /DE | View Filing | |
| form 4 | Form 4 — HOOLEY JOSEPH L | View Filing | |
| edgar index | SCHEDULE 13G/A — IDEXX LABORATORIES INC /DE | View Filing | |
| edgar index | DEF 14A — IDEXX LABORATORIES INC /DE | View Filing | |
| edgar index | DEFA14A — IDEXX LABORATORIES INC /DE | View Filing | |
| edgar index | ARS — IDEXX LABORATORIES INC /DE | View Filing | |
| edgar index | 8-K — IDEXX LABORATORIES INC /DE | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| edgar index | PRE 14A — IDEXX LABORATORIES INC /DE | View Filing | |
| edgar index | 4 — IDEXX LABORATORIES INC /DE | View Filing | |
| edgar index | 4 — IDEXX LABORATORIES INC /DE | View Filing | |
| edgar index | 4/A — IDEXX LABORATORIES INC /DE | View Filing |